We are live on ! Find out more

Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
MBRX icon
501
Moleculin Biotech
MBRX
$8.05M
$8.05M $7.90 9.4%
ACTU icon
502
Actuate Therapeutics
ACTU
$8.05M
$8.05M $0.3351 9.68%
SNGX icon
503
Soligenix
SNGX
$7.75M
$7.75M $0.3559 3.63%
VTGN icon
504
VistaGen Therapeutics
VTGN
$7.47M
$7.47M $0.1683 1.41%
MTVA icon
505
MetaVia Inc
MTVA
$7.38M
$7.38M $1.12 5.88%
LEXX icon
506
Lexaria Bioscience
LEXX
$7.35M
$7.35M $3.49 7.43%
CNSP icon
507
CNS Pharmaceuticals
CNSP
$7.31M
$7.31M $5 4.82%
IMRN icon
508
Immuron
IMRN
$7.1M
$7.1M $0.8800 4.61%
KPRX icon
509
Kiora Pharmaceuticals
KPRX
$6.9M
$6.9M $1.56 11.4%
XCUR icon
510
Exicure
XCUR
$6.61M
$6.61M $1.01 8.04%
FBLG icon
511
FibroBiologics
FBLG
$6.59M
$6.59M $0.9300 0.2%
ENVB icon
512
Enveric Biosciences
ENVB
$6.4M
$6.4M $1.43 2.05%
SNTI icon
513
Senti Biosciences Holdings
SNTI
$6.35M
$6.35M $0.1651 23.9%
APRE icon
514
Aprea Therapeutics
APRE
$6.1M
$6.1M $0.4846 1.82%
ALZN icon
515
Alzamend Neuro
ALZN
$5.84M
$5.84M $1.21 0.82%
ACXP icon
516
Acurx Pharmaceuticals
ACXP
$5.69M
$5.69M $1.04 2.8%
SKYE icon
517
Skye Bioscience
SKYE
$5.67M
$5.67M $1.28 2.29%
ADXN icon
518
Addex Therapeutics
ADXN
$5.42M
$5.42M $3.09 5.46%
LGVN
519
Longeveron
LGVN
$5.32M
$5.32M $1.67 4.57%
PCSA icon
520
Processa Pharmaceuticals
PCSA
$5.28M
$5.28M $1.89 0%
PULM icon
521
Pulmatrix
PULM
$5.11M
$5.11M $1.40 1.41%
EVGN icon
522
Evogene
EVGN
$5.09M
$5.09M $0.3746 1.52%
CELZ icon
523
Creative Medical Technology
CELZ
$4.97M
$4.97M $0.6550 3.45%
TCRT icon
524
Alaunos Therapeutics
TCRT
$4.95M
$4.95M $1.95 3.17%
CDIO icon
525
Cardio Diagnostics
CDIO
$4.94M
$4.94M $1.67 4.57%
19 20
21
22 23

Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 570 Biotechnology industry stocks tracked by Wall St. Rank, worth a combined $1.31T.

The largest by market cap are Vertex Pharmaceuticals (VRTX) at $142B, Regeneron Pharmaceuticals (REGN) at $96B and Moderna (MRNA) at $88.5B.

Among institutional investors, Revolution Medicines (RVMD) drew the most net new fund positions in Q2 2026: 246 funds opened new positions, taking total fund holders up 181 (35%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.